Pear Therapeutics, developer of several digital therapeutics for addiction, has announced that it will be restructuring to save money.
The announcement was made after market close on 25 July.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?